Dr. Bo Ying, Founder, Chairman, and CEO of Abogen Biosciences, will attend the symposium CRSingapore 2025 Connecting Continents in Delivery Science hosted by the Controlled Release Society (CRS) in Singapore in February 2025. As a keynote speaker, Dr. Bo Ying will join global scientists and clinical experts to discuss the latest advancements in delivery science and present industrial perspective on mRNA-based therapeutics and vaccines.
Delivery science, regarded as the “last mile” of drug development, has garnered significant attention particularly within the realm of mRNA therapeutics. Looking ahead, innovations and breakthroughs in delivery technology, such as improving delivery efficiency and non-hepatic targeting, are anticipated to further expand the applications of RNA therapeutics, thereby unlocking new frontiers in the field.
The CRS Singapore Symposium of delivery science is jointly organized by the Controlled Release Society (CRS), the National University of Singapore (NUS), and the National University Health System (NUHS). This prestigious event will bring together leading industrial experts, scholars, and corporate representatives from around the globe to exchange cutting-edge scientific discoveries and technological advancements. The symposium aims to foster cross-border collaboration, building a technological bridge connecting continents, and collectively paving the way for a more efficient and cohesive future of drug delivery science.
Dr. Bo Ying’s Keynote Presentation
Time: February 20, 2025, 14:45–15:10
Topic: Industrial perspective of mRNA-based therapeutics and vaccines
The Controlled Release Society (CRS) is a globally recognized organization dedicated to the delivery of drugs, cosmetics, fragrances and other actives. CRS members drive the future of drug delivery science and technology through fundamental delivery research, development, regulatory science, and clinical translation. CRS has hosted a number of thematic symposia and annual meetings addressing cutting-edge topics in mRNA-based therapeutics, oral drug delivery, an outlook for future drug delivery and diagnostics, women’s health, pediatric drug development, etc.
For more information about the event, check the official website:
media@abogenbio.com
